The Deerfield, Ill.-based company said Oct. 28 that it will close its roughly 160 in-store health clinics it runs itself but keep open the 220 clinics that are run by local health systems. It didn’t give an estimate of the financial impact.
Walgreens has used in-store health clinics to treat chronically ill patients as a way to offset slowing revenue from prescription drugs and competition from online retailers, according to the WSJ. To do so, Walgreens has increasingly pursued partnerships with other companies and health systems.
Walgreens’ roughly 400 walk-in clinics have at best barely broken even for the company, so its new goal is to shift away from treating minor illnesses to focusing on chronic care for patients with conditions including diabetes, heart disease and hypertension.
The news of the company’s decision to close its clinics came as it posted a 55 percent drop in quarterly profit.
Read the full article here.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
